Contract Pharma Lean Six

Demand for pathology services sparks PPD, NeoGenomics alliance

Collaboration to provide a seamless and fully integrated global pathology and molecular testing solution to PPD’s pharmaceutical and biotech clients.

Outsourcing-Pharma  (June 2018)

Biopharma business booming in Middleton

PPD® Laboratories has been expanding its operations in Middleton over the past few years, increasing its highly scientific workforce by 50 percent during that time.

Wisconsin State Journal  (June 2018)

The outsourcing balancing act

Leona Fitzgerald and Denise Moody talk about achieving the best balance of oversight and involvement.

Contract Pharma  (June 2018)

PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry

In this article and video, Jon Denissen discusses how PPD Laboratories is keeping up with the demand for biopharmaceuticals.

Outsourcing-Pharma  (June 2018)

PPD, Evidera join MIT ‘think and do’ tank as a strategic partner

PPD becomes the first contract research organization to join the MIT Center for Biomedical Innovation’s New Drug Development Paradigms (NEWDIGS).

Outsourcing-Pharma  (May 2018)

FDA Regenerative Medicine Policy Framework and Advanced Therapy Designation

Richard Dennett and Kirsten Messmer provide an overview of the policy framework established by the U.S. Food and Drug Administration for the regulation of regenerative medicine and advanced therapies.

Regulatory Focus  (May 2018)

CRO Industry Update: Big Data Drives Drug Development Efforts

PPD’s David Johnston and Evidera’s Eric Faulkner comment on the changing clinical development landscape.

Contract Pharma  (May 2018)

Today’s Feasibility Challenge: Harnessing Data to Deliver Patients into Clinical Trials

Gaurav Bhatnagar discusses how data-driven feasibility assessment is at the heart of the emerging evidence-based clinical trial process.

CenterWatch Monthly  (May 2018)

CRO’s FSP model proves to be the right choice

Gary Barker, Denise Moody, April Pierce and Magda Santos explain how PPD used an FSP model to help build a solid, long-term partnership with a top 25 pharmaceutical organization.

Pharmaceutical Outsourcing   (May 2018)

Acurian, Synexus tap database of 100m for NASH patient enrollment solution

The companies will combine efforts to enable trial sponsors to find, qualify and enroll NAFLD and NASH patients more effectively and efficiently.

Outsourcing-Pharma  (April 2018)

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.